Display Settings:

Format

Send to:

Choose Destination
    F1000 Med Rep. 2011;3:12. Epub 2011 Jun 1.

    Alloantigen-based AIDS vaccine: revisiting a "rightfully" discarded promising strategy.

    Abstract

    This report revisits the accidental discovery that protection against simian immunodeficiency virus (SIV) infection in the early successful experimental AIDS vaccine studies in Rhesus macaques was due to antibodies directed against human leukocyte antigens (HLAs). The inactivated virus vaccine approach was discarded because protection was due to the host's immune reaction against the HLA acquired by SIV from the human cell lines in which it was grown, rather than against antigenic determinants of SIV itself. Subsequent studies have revealed that immune recognition of HLA on uninfected leukocytes also induces other factors that inhibit infection by both SIV and the human immunodeficiency virus. Pro and con aspects of immunization against HLA as a potential AIDS vaccine strategy are discussed.

    PMID:
    21876718
    [PubMed]
    PMCID:
    PMC3155155
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure 1.

      Supplemental Content

      Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk